Krilogy Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.13M | Sell |
5,876
-267
| -4% | -$91.4K | 0.06% | 229 |
|
|
2026
Q1 | $2.15M | Buy |
6,143
+1,431
| +30% | +$510K | 0.07% | 214 |
|
|
2025
Q4 | $1.65M | Buy |
4,712
+296
| +7% | +$93.9K | 0.06% | 243 |
|
|
2025
Q3 | $1.41M | Buy |
+4,416
| New | +$1.28M | 0.05% | 254 |
|
|
2023
Q2 | – | Sell |
-4,365
| Closed | -$1.06M | – | 212 |
|
|
2023
Q1 | $1.06M | Sell |
4,365
-58
| -1% | -$14.2K | 0.09% | 178 |
|
|
2022
Q4 | $1.16M | Sell |
4,423
-492
| -10% | -$132K | 0.11% | 148 |
|
|
2022
Q3 | $1.11M | Sell |
4,915
-80
| -2% | -$19.4K | 0.13% | 104 |
|
|
2022
Q2 | $1.22M | Sell |
4,995
-868
| -15% | -$213K | 0.14% | 95 |
|
|
2022
Q1 | $1.42M | Buy |
5,863
+2,679
| +84% | +$616K | 0.14% | 95 |
|
|
2021
Q4 | $716K | Sell |
3,184
-379
| -11% | -$80K | 0.07% | 161 |
|
|
2021
Q3 | $758K | Buy |
3,563
+416
| +13% | +$95.7K | 0.08% | 158 |
|
|
2021
Q2 | $767K | Sell |
3,147
-216
| -6% | -$53.1K | 0.08% | 153 |
|
|
2021
Q1 | $837K | Sell |
3,363
-330
| -9% | -$78.7K | 0.09% | 140 |
|
|
2020
Q4 | $849K | Buy |
3,693
+15
| +0.4% | +$3.46K | 0.1% | 133 |
|
|
2020
Q3 | $935K | Buy |
3,678
+1,052
| +40% | +$261K | 0.13% | 110 |
|
|
2020
Q2 | $619K | Buy |
2,626
+567
| +28% | +$129K | 0.09% | 138 |
|
|
2020
Q1 | $417K | Sell |
2,059
-78
| -4% | -$17K | 0.08% | 139 |
|
|
2019
Q4 | $515K | Buy |
2,137
+32
| +2% | +$7.05K | 0.08% | 124 |
|
|
2019
Q3 | $407K | Sell |
2,105
-1,090
| -34% | -$209K | 0.07% | 128 |
|
|
2019
Q2 | $589K | Buy |
3,195
+638
| +25% | +$114K | 0.11% | 98 |
|
|
2019
Q1 | $486K | Buy |
2,557
+7
| +0.3% | +$1.34K | 0.1% | 109 |
|
|
2018
Q4 | $496K | Buy |
2,550
+305
| +14% | +$59.5K | 0.14% | 73 |
|
|
2018
Q3 | $465K | Buy |
2,245
+4
| +0.2% | +$788 | 0.11% | 81 |
|
|
2018
Q2 | $414K | Buy |
2,241
+5
| +0.2% | +$884 | 0.1% | 86 |
|
|
2018
Q1 | $381K | Buy |
2,236
+241
| +12% | +$44.2K | 0.09% | 101 |
|
|
2017
Q4 | $347K | Sell |
1,995
-221
| -10% | -$39.1K | 0.08% | 107 |
|
|
2017
Q3 | $413K | Sell |
2,216
-909
| -29% | -$161K | 0.11% | 93 |
|
|
2017
Q2 | $538K | Buy |
3,125
+1,062
| +51% | +$173K | 0.15% | 65 |
|
|
2017
Q1 | $302K | Hold |
2,063
| – | – | 0.09% | 94 |
|
|
2016
Q4 | $302K | Buy |
2,063
+836
| +68% | +$126K | 0.09% | 94 |
|
|
2016
Q3 | $205K | Sell |
1,227
-269
| -18% | -$45.5K | 0.07% | 119 |
|
|
2016
Q2 | $228K | Buy |
1,496
+1,136
| +316% | +$177K | 0.08% | 111 |
|
|
2016
Q1 | $54K | Buy |
360
+130
| +57% | +$19.3K | 0.02% | 256 |
|
|
2015
Q4 | $37K | Buy |
+230
| New | +$36.2K | 0.03% | 157 |
|
Other funds holding AMGN
Krilogy Financial's AMGN Position: Q2 2026 in Review
Krilogy Financial reduced its Amgen (AMGN) stake by 4.3% in Q2 2026, selling an estimated $91.4K and leaving 5,876 shares worth $2.13M. The position accounts for 0.06% of the portfolio, ranked #229.
Krilogy Financial first reported a position in AMGN in Q4 2015 and has held it in 34 quarters since. The position peaked at $2.15M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Krilogy Financial held 5,876 shares of Amgen worth $2.13M as of Q2 2026.
- Krilogy Financial sold 267 Amgen shares in Q2 2026, an estimated $91.4K.
- Amgen made up 0.06% of Krilogy Financial's portfolio in Q2 2026, its #229 holding.
- Krilogy Financial first reported a position in Amgen in Q4 2015 and has held it in 34 quarters since.
- Krilogy Financial's Amgen position peaked at $2.15M in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.